These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4399747)

  • 1. Intrinsic sympathomimetic activity in relation to the precipitation of heart failure by beta-adrenoceptive blockade.
    Barrett AM; Nunn B
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):168-74. PubMed ID: 4399747
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW; Braunwald E
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific differences between the adrenergic beta receptors of the heart and coronary vessels].
    Bayer BL; Mentz P; Förster W
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):341-7. PubMed ID: 4405155
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
    Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inosine as a cardiotonic agent that reverses adrenergic beta blockade.
    Juhász-Nagy A; Aviado DM
    J Pharmacol Exp Ther; 1977 Sep; 202(3):683-95. PubMed ID: 197230
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR; Gupta RS; Jain BK
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract]   [Full Text] [Related]  

  • 10. Selectivity of beta-adrenergic compounds. III - Classification of beta-receptors.
    Grana E; Lucchelli A; Zonta F
    Farmaco Sci; 1974 Oct; 29(10):786-92. PubMed ID: 4154868
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of verapamil-, dichloroisoproterenol-, and propranolol-induced cardiac failure by histamine.
    Bernauer W; Schanz HM
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):197-207. PubMed ID: 4151236
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myocardial contractility and drug effects with special reference to the adrenergic mechanism].
    Otorii T; Imai S
    Nihon Rinsho; 1972 Oct; 30(10):2043-50. PubMed ID: 4405499
    [No Abstract]   [Full Text] [Related]  

  • 13. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors.
    Harms HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):329-35. PubMed ID: 10427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on beta-adrenoceptor mediated facilitation of sympathetic neurotransmission.
    Dahlöf C
    Acta Physiol Scand Suppl; 1981; 500():1-147. PubMed ID: 6123220
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adrenergic components of direct coronary and cardiac action of nitroglycerin].
    Bayer BL; Mentz P; Förster W
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):55-60. PubMed ID: 4155278
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of potencies of six beta-adrenoceptive blocking drugs in isolated rabbit atrium and guinea-pig trachea (author's transl)].
    Mao YK; Yang ZC
    Zhongguo Yao Li Xue Bao; 1980 Sep; 1(1):7-12. PubMed ID: 6121446
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac actions of oxprenolol as studied in dog heart-lung preparations.
    Takeda K; Iizuka H; Imai S
    Arzneimittelforschung; 1973 Oct; 23(10):1446-50. PubMed ID: 4149692
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.